Vertex Pharmaceuticals (VRTX) Gross Margin Growth (1y) (2010 - 2026)

Vertex Pharmaceuticals (VRTX) Gross Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -93.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -91.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 236.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 228.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 6.06 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -475.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 1,034.00
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -1,260.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -93.00
Mar 31, 2026 -5.00
Dec 31, 2025 -7.00
Sep 30, 2025 68.00
Jun 30, 2025 31.00
Mar 31, 2025 -37.00
Dec 31, 2024 8.00
Sep 30, 2024 -133.00
Jun 30, 2024 -168.00
Mar 31, 2024 -149.00
Dec 31, 2023 -231.00
Sep 30, 2023 -43.00
Jun 30, 2023 -46.00
Mar 31, 2023 48.00
Dec 31, 2022 -37.00
Sep 30, 2022 -48.00
Jun 30, 2022 79.00
Mar 31, 2022 -57.00
Dec 31, 2021 54.00
Sep 30, 2021 18.00